Preventing hernias after abdominal surgery with mesh
Prospective, Multi-Center, Open-Label, Randomized, Controlled Trial of Phasix™ Mesh to Prevent Incisional Hernia Subsequent to Open Midline Laparotomy
This study is testing if using a special mesh instead of regular stitches during abdominal surgery can help prevent hernias in adults who are at risk.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 477 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | C. R. Bard Industry-sponsored |
| Locations | 44 sites (Phoenix, Arizona and 43 other locations) |
| Trial ID | NCT03911700 on ClinicalTrials.gov |
What this trial studies
This trial evaluates the effectiveness of Phasix™ Mesh implantation during the closure of midline abdominal incisions compared to traditional suture closure. Participants will be randomly assigned to receive either the mesh or standard sutures after undergoing open midline laparotomy surgery. The goal is to determine if the mesh can reduce the incidence of incisional hernias in patients at moderate or higher risk. The study will involve subjects aged 18 and older who meet specific eligibility criteria.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who are undergoing elective open midline laparotomy and are at moderate or greater risk for incisional hernia.
Not a fit: Patients who have previously had hernia repairs or are undergoing emergency surgeries may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the risk of incisional hernias in patients undergoing open midline laparotomy.
How similar studies have performed: Other studies have shown promising results with the use of mesh in hernia prevention, suggesting that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Must be ≥ 18 years of age 2. Elective, open midline laparotomy ≥ 5 cm 3. Willing and able to provide written informed consent 4. Hernia risk equal to moderate or greater Exclusion Criteria: 1. Previous hernia repair 2. Emergent surgery 3. Creation of skin flaps is preplanned 4. Preplanned 2nd surgery 5. Active skin pathology 6. Life expectancy less than 24 months 7. Pregnant or planning to become pregnant 8. Receiving a medication/medical condition that may adversely affect wound healing 9. ASA Class \> IV 10. Enrolled in another clinical trial 11. Site personnel directly involved with this trial 12. Any condition that would preclude the use of the device or the subject form completing the follow-up requirements 13. Known or suspected allergy to tetracycline hydrochloride or kanamycin sulfate 14. Two separate incisions are created 15. Prior onlay mesh 16. Surgeon is unable to fully close the fascia 17. The surgery requires more than a single piece of mesh 18. Contraindication to placement of mesh 19. CDC Class IV/Active Infection 20. Breastfeeding
Where this trial is running
Phoenix, Arizona and 43 other locations
- Dignity Health — Phoenix, Arizona, United States (Recruiting)
- Keck Medical Center of USC — Los Angeles, California, United States (Withdrawn)
- University of California San Francisco — San Francisco, California, United States (Recruiting)
- Hartford Hospital — Hartford, Connecticut, United States (Active_not_recruiting)
- St. Francis Hospital and Medical Center — Hartford, Connecticut, United States (Withdrawn)
- Emory University — Atlanta, Georgia, United States (Terminated)
- OSF Saint Francis Medical Center — Peoria, Illinois, United States (Active_not_recruiting)
- Indiana University — Indianapolis, Indiana, United States (Active_not_recruiting)
- University of Kentucky Research Foundation — Lexington, Kentucky, United States (Recruiting)
- Tulane University School of Medicine — New Orleans, Louisiana, United States (Recruiting)
- University of Michigan — Ann Arbor, Michigan, United States (Withdrawn)
- Minneapolis VA Health Care System — Minneapolis, Minnesota, United States (Withdrawn)
- University of Minnesota — Minneapolis, Minnesota, United States (Recruiting)
- St. Luke's Hospital — Kansas City, Missouri, United States (Withdrawn)
- Cox Health — Springfield, Missouri, United States (Withdrawn)
- Washington University — St Louis, Missouri, United States (Recruiting)
- Nebraska Medical Center — Omaha, Nebraska, United States (Withdrawn)
- Nebraska Methodist Hospital — Omaha, Nebraska, United States (Withdrawn)
- Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey, United States (Recruiting)
- New York Presbyterian Hospital-Columbia University Medical Center — New York, New York, United States (Active_not_recruiting)
- Montefiore Medical Center — The Bronx, New York, United States (Active_not_recruiting)
- Atrium Health — Charlotte, North Carolina, United States (Active_not_recruiting)
- Duke University — Durham, North Carolina, United States (Withdrawn)
- New Hanover Regional Medical Center — Wilmington, North Carolina, United States (Recruiting)
- The Ohio State University — Columbus, Ohio, United States (Recruiting)
- Oregon Health & Science University — Portland, Oregon, United States (Withdrawn)
- University of Pennsylvania — Philadelphia, Pennsylvania, United States (Recruiting)
- Baptist Clinical Research Institute — Memphis, Tennessee, United States (Active_not_recruiting)
- Vanderbilt University — Nashville, Tennessee, United States (Recruiting)
- CAMC Health Education and Research Institute, Inc. — Charleston, West Virginia, United States (Active_not_recruiting)
- Krankenhaus der Barmherzigen Brüder Graz — Graz, Austria (Recruiting)
- Universitair Ziekenhuis Gent — Ghent, Belgium (Recruiting)
- CHU de Dijon Bourgogne — Dijon, France (Recruiting)
- Centre Hospitalier Universitaire de Lille — Lille, France (Recruiting)
- Centre Hospitalier Universitaire de Lille — Lille, France (Recruiting)
- Hôpital Paris St Joseph — Paris, France (Recruiting)
- Hôpital Lyon Sud — Pierre-Bénite, France (Recruiting)
- CHU Reims — Reims, France (Recruiting)
- Hopitaux Universitaires de Strasbourg — Strasbourg, France (Recruiting)
- Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum, Gyneocology — Berlin, Germany (Withdrawn)
- Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum, Surgery — Berlin, Germany (Withdrawn)
- Asklepios Klinik Barmbek — Hamburg, Germany (Recruiting)
- Universitätsklinikum Heidelberg — Heidelberg, Germany (Recruiting)
- Bundeswehrzentralkrankenhaus Koblenz — Koblenz, Germany (Recruiting)
Study contacts
- Principal investigator: William Hope, MD — New Hanover Regional Medical Center
- Study coordinator: Amanda Resendes, MBA
- Email: amanda.resendes@bd.com
- Phone: 401-209-7141
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.